New MRI technique could end guesswork in brain tumor Follow-Up

NCT ID NCT07687277

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether a special type of MRI scan can tell the difference between actual tumor growth and harmless treatment-related changes in people who have had surgery for a type of brain cancer called glioma. After treatment, it's often hard to know if a new spot on a scan means the cancer is coming back or is just a temporary reaction. The researchers will use two advanced MRI techniques—3D-ASL and time-dependent diffusion MRI—to measure blood flow and water movement in the brain. If the method works, it could help doctors make better decisions without needing invasive biopsies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multiparametric MRI (3D-ASL and TDD-MRI)
What this could lead to
If successful, this imaging method could help doctors accurately tell whether a brain tumor is growing or just reacting to treatment, reducing unnecessary surgeries or therapies.
What could go wrong
This is a small, early-stage study. The technique may not be accurate enough to replace current methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lanzhou University Second Hospital

    Lanzhou, Gansu, 730030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.